LT5079B - Avies pararaupų viruso kamienų panaudojimas antivirusinių ir priešvėžinių vaistų gamybai - Google Patents
Avies pararaupų viruso kamienų panaudojimas antivirusinių ir priešvėžinių vaistų gamybai Download PDFInfo
- Publication number
- LT5079B LT5079B LT2003009A LT2003009A LT5079B LT 5079 B LT5079 B LT 5079B LT 2003009 A LT2003009 A LT 2003009A LT 2003009 A LT2003009 A LT 2003009A LT 5079 B LT5079 B LT 5079B
- Authority
- LT
- Lithuania
- Prior art keywords
- viruses
- viral
- fragments
- treatment
- virus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Surgery (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10033582 | 2000-07-11 | ||
DE10122451A DE10122451A1 (de) | 2000-07-11 | 2001-05-09 | Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs |
Publications (2)
Publication Number | Publication Date |
---|---|
LT2003009A LT2003009A (en) | 2003-08-25 |
LT5079B true LT5079B (lt) | 2003-12-29 |
Family
ID=26006335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LT2003009A LT5079B (lt) | 2000-07-11 | 2003-02-03 | Avies pararaupų viruso kamienų panaudojimas antivirusinių ir priešvėžinių vaistų gamybai |
Country Status (36)
Country | Link |
---|---|
US (1) | US6685950B2 (sv) |
EP (1) | EP1303286B1 (sv) |
JP (1) | JP5037775B2 (sv) |
CN (1) | CN1455674B (sv) |
AR (1) | AR029954A1 (sv) |
AT (1) | ATE324115T1 (sv) |
AU (2) | AU7063101A (sv) |
BG (1) | BG107448A (sv) |
CA (1) | CA2415397C (sv) |
CY (1) | CY1105408T1 (sv) |
CZ (1) | CZ200371A3 (sv) |
DE (1) | DE50109630D1 (sv) |
DK (2) | DK1303286T3 (sv) |
EE (1) | EE200300018A (sv) |
ES (1) | ES2262663T3 (sv) |
FI (1) | FI20030037A (sv) |
GB (1) | GB2381454B8 (sv) |
HK (1) | HK1054329B (sv) |
HR (1) | HRP20030096A2 (sv) |
HU (1) | HUP0400479A3 (sv) |
IL (1) | IL153643A0 (sv) |
LT (1) | LT5079B (sv) |
LU (1) | LU90997B1 (sv) |
LV (1) | LV12990B (sv) |
MA (1) | MA26927A1 (sv) |
MX (1) | MXPA03000279A (sv) |
NO (1) | NO20030082D0 (sv) |
NZ (1) | NZ523534A (sv) |
PL (1) | PL366397A1 (sv) |
PT (1) | PT1303286E (sv) |
RU (1) | RU2003104525A (sv) |
SE (1) | SE0300034L (sv) |
SI (1) | SI21122A (sv) |
SK (1) | SK362003A3 (sv) |
UY (1) | UY26832A1 (sv) |
WO (1) | WO2002004002A2 (sv) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
US7628980B2 (en) * | 2000-11-23 | 2009-12-08 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
US7097842B2 (en) * | 2000-11-23 | 2006-08-29 | Bavarian Nordic A/S | Modified vaccinia virus ankara for the vaccination of neonates |
EE05680B1 (et) * | 2000-11-23 | 2013-10-15 | Bavarian Nordic A/S | Muundatud vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ning vaktsiin |
NZ512341A (en) | 2001-06-13 | 2004-02-27 | Bayer Ag | Polynucleotides between 15 and 100 base pairs in length coding for parapoxvirus ovis (PPVO)/vaccinia virus recombinant (VVOV) viral genome fragments |
WO2003050135A2 (en) | 2001-12-07 | 2003-06-19 | Board Of Regents The University Of Texas System | Use a parapox b2l protein to modify immune responses to administered antigens |
PL220781B1 (pl) * | 2002-04-19 | 2016-01-29 | Bavarian Nordic As | Zastosowanie wirusa krowianki Ankara (MVA) szczepu MVA-BN |
KR101044538B1 (ko) * | 2002-09-05 | 2011-06-27 | 버베리안 노딕 에이/에스 | 무혈청 조건하에서 일차세포의 배양 및 바이러스의 증식방법 |
DE602005016552D1 (de) * | 2004-07-13 | 2009-10-22 | Aicuris Gmbh & Co Kg | Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids |
CA2630833C (en) * | 2005-11-24 | 2015-01-06 | Aicuris Gmbh & Co. Kg | Parapoxviruses in combination with classical cytotoxic chemotherapeutic agents as biochemotherapy for the treatment of cancer |
JP5004990B2 (ja) * | 2009-03-31 | 2012-08-22 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフト | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 |
ES2626595T5 (es) * | 2009-12-18 | 2021-11-24 | Bavarian Nordic As | Producción de IFN-lambda por células dendríticas convencionales y usos de las mismas |
JP5699093B2 (ja) * | 2012-01-05 | 2015-04-08 | アイキュリス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトAiCuris GmbH & Co. KG | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 |
TW201919675A (zh) * | 2017-09-07 | 2019-06-01 | 德商艾庫瑞斯公司 | 使用羊副痘疹病毒(Parapoxvirus ovis;PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法 |
WO2023083950A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with immunomodulators |
WO2023083943A1 (en) * | 2021-11-10 | 2023-05-19 | Aicuris Gmbh & Co. Kg | Parapoxvirus for preparing for and treatment of respiratory virus infections in combination with antivirals |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504940A1 (de) | 1984-02-17 | 1985-10-31 | Mayr, Anton, Prof. Dr.med.vet. Dr.h.c.mult., 8000 München | Multipotente paramunitaetsmediatoren, verfahren zu ihrer herstellung und diese mediatoren enthaltende arzneimittel |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
US5443964A (en) * | 1987-08-10 | 1995-08-22 | Duke University | Poxvirus insertion/expression vector |
DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
EP0886679B1 (de) * | 1996-02-28 | 2007-06-06 | Bayer HealthCare AG | Parapockenviren, die fremd-dna enthalten, ihre herstellung und ihre verwendung in impfstoffen |
CN1217751A (zh) * | 1996-03-29 | 1999-05-26 | 奥塔戈大学 | 副痘病毒载体 |
SI0885013T1 (sv) * | 1996-04-15 | 2001-12-31 | Anton Mayr | |
SE9700617D0 (sv) * | 1997-02-21 | 1997-02-21 | Kjell Alving | New composition |
DE19843222A1 (de) * | 1998-09-22 | 2000-03-30 | Hassan Jomaa | Verwendung von phosphororganischen Verbindungen zur therapeutischen und prophylaktischen Behandlung von Infektionen |
WO2000025805A1 (en) * | 1998-11-02 | 2000-05-11 | Ludwig Institute For Cancer Research | Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2 |
-
2001
- 2001-07-11 LU LU90997A patent/LU90997B1/en active
- 2001-07-11 JP JP2002508456A patent/JP5037775B2/ja not_active Expired - Lifetime
- 2001-07-11 DK DK01949489T patent/DK1303286T3/da active
- 2001-07-11 EE EEP200300018A patent/EE200300018A/xx unknown
- 2001-07-11 SI SI200120048A patent/SI21122A/sl not_active IP Right Cessation
- 2001-07-11 PT PT01949489T patent/PT1303286E/pt unknown
- 2001-07-11 UY UY26832A patent/UY26832A1/es not_active Application Discontinuation
- 2001-07-11 CN CN01812685.5A patent/CN1455674B/zh not_active Expired - Lifetime
- 2001-07-11 GB GB0302630A patent/GB2381454B8/en not_active Expired - Fee Related
- 2001-07-11 AT AT01949489T patent/ATE324115T1/de active
- 2001-07-11 WO PCT/EP2001/007991 patent/WO2002004002A2/de active IP Right Grant
- 2001-07-11 IL IL15364301A patent/IL153643A0/xx active IP Right Grant
- 2001-07-11 ES ES01949489T patent/ES2262663T3/es not_active Expired - Lifetime
- 2001-07-11 AR ARP010103292A patent/AR029954A1/es unknown
- 2001-07-11 DE DE50109630T patent/DE50109630D1/de not_active Expired - Lifetime
- 2001-07-11 AU AU7063101A patent/AU7063101A/xx active Pending
- 2001-07-11 SK SK36-2003A patent/SK362003A3/sk not_active Application Discontinuation
- 2001-07-11 NZ NZ523534A patent/NZ523534A/en not_active IP Right Cessation
- 2001-07-11 CZ CZ200371A patent/CZ200371A3/cs unknown
- 2001-07-11 EP EP01949489A patent/EP1303286B1/de not_active Expired - Lifetime
- 2001-07-11 AU AU2001270631A patent/AU2001270631B2/en not_active Expired - Fee Related
- 2001-07-11 MX MXPA03000279A patent/MXPA03000279A/es unknown
- 2001-07-11 CA CA2415397A patent/CA2415397C/en not_active Expired - Lifetime
- 2001-07-11 HU HU0400479A patent/HUP0400479A3/hu unknown
- 2001-07-11 US US09/903,013 patent/US6685950B2/en not_active Expired - Lifetime
- 2001-07-11 PL PL01366397A patent/PL366397A1/xx not_active Application Discontinuation
- 2001-07-11 RU RU2003104525/15A patent/RU2003104525A/ru not_active Application Discontinuation
-
2003
- 2003-01-08 BG BG107448A patent/BG107448A/bg unknown
- 2003-01-08 NO NO20030082A patent/NO20030082D0/no unknown
- 2003-01-10 FI FI20030037A patent/FI20030037A/sv not_active IP Right Cessation
- 2003-01-10 SE SE0300034A patent/SE0300034L/sv not_active Application Discontinuation
- 2003-01-10 DK DK200300015A patent/DK200300015A/da not_active Application Discontinuation
- 2003-01-10 MA MA26994A patent/MA26927A1/fr unknown
- 2003-02-03 LT LT2003009A patent/LT5079B/lt not_active IP Right Cessation
- 2003-02-10 HR HR20030096A patent/HRP20030096A2/xx not_active Application Discontinuation
- 2003-02-11 LV LVP-03-14A patent/LV12990B/lv unknown
- 2003-09-15 HK HK03106613.1A patent/HK1054329B/zh not_active IP Right Cessation
-
2006
- 2006-07-24 CY CY20061101024T patent/CY1105408T1/el unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3504940A1 (de) | 1984-02-17 | 1985-10-31 | Mayr, Anton, Prof. Dr.med.vet. Dr.h.c.mult., 8000 München | Multipotente paramunitaetsmediatoren, verfahren zu ihrer herstellung und diese mediatoren enthaltende arzneimittel |
Non-Patent Citations (8)
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LT5079B (lt) | Avies pararaupų viruso kamienų panaudojimas antivirusinių ir priešvėžinių vaistų gamybai | |
Zawatzky et al. | The Role of Interferon in the Resistance of CS7BL/6 Mice to Various Doses of Herpes Simplex Virus Type 1 | |
KR20180021083A (ko) | 바이러스성 색전술을 위한 조성물 및 방법 | |
Alfano et al. | New players in cytokine control of HIV infection | |
CN111588721A (zh) | 化合物zl0580用于预防或治疗非洲猪瘟的新用途 | |
Ruansit et al. | Oral supplementation of quercetin in PRRSV-1 modified-live virus vaccinated pigs in response to HP-PRRSV-2 challenge | |
Stringfellow et al. | Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis | |
JP2012121902A (ja) | 抗ウイルス薬および癌に対する医薬を製造するためのパラポックスウイルスovis株の使用 | |
JP5636284B2 (ja) | フィロウイルスまたはアレナウイルス感染の暴露前または暴露後の治療法 | |
IL176634A (en) | Monoparamunity inducers based on attenuated rabbit myxoma viruses | |
WO2006108358A1 (fr) | UTILISATION ANTIVIRALE D’OLIGODESOXYNUCLEOTIDES ARTIFICIELS A UN SEUL BRIN CONTENANT UN CpG EN COMBINAISON AVEC LA RIBAVIRINE | |
CN111686107B (zh) | 化合物plx51107用于制备预防或治疗非洲猪瘟药物的新用途 | |
Webster | Virus infections in primary immunodeficiency. | |
Kim et al. | Intranasal treatment with CpG-B oligodeoxynucleotides protects CBA mice from lethal equine herpesvirus 1 challenge by an innate immune response | |
JP2000007578A (ja) | C型肝炎ウイルスの陰性化のための投薬システム | |
JP2000501114A (ja) | 弱毒化された非免疫原性ポックスウイルスまたはパラポックスウイルスからの多種有効性パラポックス免疫誘導剤の薬剤としての使用のための新規薬効 | |
Brandao et al. | Prolonged survival of rabid mice after treatment with Poly-ICLC Hiltonol (R) | |
SARZOTTI et al. | LFN-γ Production in Response to Neuropathogenic Cas-Br-M Murine Leukemia Virus Infection | |
CN106581052A (zh) | 柠檬酸根离子和铁离子在抑制rna病毒中的应用 | |
CN118127004A (zh) | 靶向HSV必需基因的gRNA、CRISPR/Cas基因编辑系统、递送系统及应用 | |
CN1604789A (zh) | 胸腺素强化的遗传免疫方法 | |
WO1998037905A1 (en) | Arrestable therapeutic viral agent | |
Martino et al. | Treatment of Hepatic Abcesses in Chronic Granulomatous Disease with Granulomatous Disease with... | |
Francavilla et al. | Category 6: Viral hepatitis: clinical aspects 141 | |
ATAULLAKHANOV et al. | Immunomodulator Gepon suppresses the replication of Hepatitis C Virus (HCV) in human cell culture in vitro |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC9A | Transfer of patents |
Owner name: AICURIS GMBH & CO. KG, DE Effective date: 20070620 |
|
TC9A | Change of representative | ||
MM9A | Lapsed patents |
Effective date: 20140711 |